Christos Paraskeva

Bristol, ENG BS81TD, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Editor's Note: miR-153 Supports Colorectal Cancer Progression via Pleiotropic Effects That Enhance Invasion and Chemotherapeutic Resistance.

Editor's Note: miR-153 Supports Colorectal Cancer Progression via Pleiotropic Effects That Enhance Invasion and Chemotherapeutic Resistance.

Journal: Cancer research
Published: April 15, 2022

BCL‑3 promotes cyclooxygenase‑2/prostaglandin E2 signalling in colorectal cancer.

BCL‑3 promotes cyclooxygenase‑2/prostaglandin E2 signalling in colorectal cancer.

Journal: International journal of oncology
Published: September 16, 2019

BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells.

BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells.

Journal: Disease models & mechanisms
Published: October 25, 2018

The Hedgehog Inhibitor Cyclopamine Reduces β-Catenin-Tcf Transcriptional Activity, Induces E-Cadherin Expression, and Reduces Invasion in Colorectal Cancer Cells.

The Hedgehog Inhibitor Cyclopamine Reduces β-Catenin-Tcf Transcriptional Activity, Induces E-Cadherin Expression, and Reduces Invasion in Colorectal Cancer Cells.

Journal: Cancers
Published: July 12, 2015

Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells.

Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells.

Journal: British journal of cancer
Published: October 10, 2014

BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling.

BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling.

Journal: Gut
Published: August 15, 2014

miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance.

miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance.

Journal: Cancer research
Published: August 17, 2013

The retinoblastoma protein (Rb) as an anti-apoptotic factor: expression of Rb is required for the anti-apoptotic function of BAG-1 protein in colorectal tumour cells.

The retinoblastoma protein (Rb) as an anti-apoptotic factor: expression of Rb is required for the anti-apoptotic function of BAG-1 protein in colorectal tumour cells.

Journal: Cell death & disease
Published: October 13, 2012

β-catenin negatively regulates expression of the prostaglandin transporter PGT in the normal intestinal epithelium and colorectal tumour cells: a role in the chemopreventive efficacy of aspirin?

β-catenin negatively regulates expression of the prostaglandin transporter PGT in the normal intestinal epithelium and colorectal tumour cells: a role in the chemopreventive efficacy of aspirin?

Journal: British journal of cancer
Published: October 04, 2012

TGF-β1 signalling, connecting aberrant inflammation and colorectal tumorigenesis.

TGF-β1 signalling, connecting aberrant inflammation and colorectal tumorigenesis.

Journal: Current pharmaceutical design
Published: March 12, 2012

BAG-1 suppresses expression of the key regulatory cytokine transforming growth factor β (TGF-β1) in colorectal tumour cells.

BAG-1 suppresses expression of the key regulatory cytokine transforming growth factor β (TGF-β1) in colorectal tumour cells.

Journal: Oncogene
Published: February 06, 2012

Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways.

Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways.

Journal: Oncogene
Published: January 18, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026